Lunit Company Description

Lunit Inc. provides AI-powered software and solutions for cancer diagnostics and therapeutics in South Korea.

It offers AI solution for chest X-ray and mammography, as well as AI solution for digital breast tomosynthesis, and AI-powered biomarker for immune phenotyping and PD-L1 biomarker analyzer.

The company has a strategic collaboration with AstraZeneca for the development of Lunit SCOPE Genotype Predictor, an AI-powered tool capable of analyzing H&E slide images to predict the likelihood of the tumor harboring NSCLC driver mutations, such as Epidermal Growth Factor Receptor mutations.

Lunit Inc. was founded in 2013 and is based in Seoul, South Korea.

Lunit Inc.

Country	South Korea
Founded	2013
Industry	Prepackaged Software
CEO	Beomseok Brandon Suh

Contact Details

Address: K-Square Gangnam 2 Seoul South Korea
Phone	82 2 2138 0827
Website	lunit.io

Stock Details

Ticker Symbol	328130
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
ISIN Number	KR7328130000
SIC Code	7372

Key Executives

Name	Position
Beomseok Brandon Suh	Chief Executive Officer
Hyeonseong Park	Chief Financial Officer